(Spring 2021 Review) MedTech* Pain Therapeutic Device
WEARABLE MSK NEUROSTIM THERAPY TECHNOLOGY: The American pain relief treatment industry is expansive and a vastly lucrative market. It appeals greatly to the population that is drawn to the 'promise' of restoring quality of life and physical performance through the reduction/elimination of stress and discomfort. The varying range of pain treatment strategies on the market lends itself to a seemingly endless array of options for products, technologies, drugs and point of care therapies. MedTech Reviews takes on the commitment to challenge the efficacy of a selected brand based on their claims of pain therapy from their wearable therapeutic innovations. For this product review, our efficacy testers and claim challengers brought us AXIOBIONICS. In this unique observational report, Dr. Bard performs as both the actual patient (for his various physiological injuries and chronic pains) + the investigative imaging specialist, providing a complete assessment of the therapeutic process + extensive regular scanning of the musculoskeletal effects of the devices in question. (See complete report)
MedTech Performance Test/Review Project- Overview (Enlarge Video) Tech Review Part 1: Back Injury / Pain Monitoring (Enlarge Video)
Tech Review Part 2: Rib Fracture / Pain Monitoring (Enlarge Video) BEFORE/ AFTER Gait Review of Triple Flex Belt Effects (Enlarge video)

MedTech* Reviews (Imaging Solutions)
(Video - 3min)

Featuring global advancements in Elastography, digital Pet/CT scans, MRI and the Doppler Ultrasound scanning - all supporting quantifiable readings that successfully reduce/prevent unnecessary biopsies and false positives. The movement to Integrate current cancer scanning modalities paves the way for a faster, and a more accurate way of tracking cancer aggression, allowing for the adjustment of therapies as needed in a timely manner. (Versions: ENGLISH | ITALIAN | DUTCH/beta- in development)

To stay current with today's medical needs, the PORTABLE HAND-HELD ULTRASOUND DEVICE - aka the "modern stethoscope" joined the market. Powered by calibrated sound frequencies, this non-invasive scanning solution safely diagnoses the physiological condition of most vital organs and tumors in real time. The pocket-sized smart-phone integrated advancement clearly competes in resolution and performance with the over-sized hospital counterparts at a fraction of the cost! . (see Video) (Article review)

SURGICAL EVOLUTION IN BREAST CANCER LOCALIZATION: WIRE-FREE RADAR IMPLANTS - Wire-free Radar Localization is a pre-surgical procedure developed to locate and mark the exact breast abnormality through the use of a small, 12×1.6 mm implanted radar reflector device, roughly the size of a grain of rice. This micro-electronic implant communicates with the scanning handpiece, allowing the surgeon to identify the exact tissue (and how much of it) to extract during a lumpectomy. Surgical experts and diagnostic analysts present first-hand benefits and technical perspectives behind radar localization and the SCOUT® technology and the procedural advantages provided by the wire-free upgrade... (See feature article)

Explore the current technologies used in real-time tracking of Pancreatic Cancer. In patients with a family history of genetic cancers or who are otherwise at a high risk of pancreatic tumors, having the latest innovations and resources for identifying and tracking these tumors makes all the difference in every part of the treatment process. Since we're trying to avoid radiation and biopsies at any time, we use ultrasound screening as the first line scan to image the pancreas. (see Video)

Reporting on the Top Medical Innovations

Since the start of my career in the USAF medical corps, I have always held the most profound respect for NON-INVASIVE MEDICAL TECHNOLOGIES. I have witnessed the growth and expansion of safer and faster alternatives like the expanded uses and features of the ULTRASOUND, whereby in mere seconds, you can scan a patient's condition and & map out an entire treatment program from a "simple" pass of a transducer (probe). The movement of NO CUTTING and NO INJECTING means a completely visionary and streamlined upgrade to the entire patient care protocol.

BETA TESTING: MY COMMITMENT TO THE NEXT GENERATION - More than a "Tech Critic", my 35+ years in the clinical trade was the best position to give me complete access to all the latest technologies (globally), and be a TEST DRIVER of some of the most brilliant discoveries and innovations before they hit the open market. I conduct real-world applications of prototypes and even stretch its engineering limits (also known as 'battle testing') which leads to my publishing a comprehensive report support for the medical and patient communities. I take the responsibility of challenging developers' claims or validate their efficacy. I find great value in this information for use in my own practice as well as sharing this with all my colleagues across the globe. In the end, I only hope to contribute my findings to the ever-growing technology trends and advancements for patient care.

MedTech* Real-Time Remote Test Drive
April 2020- Patient 1 was quarantined due to a covid-positive test reading. MedTech Reviews producers & certified medical advisors led by Dr. Robert Bard assembled this prototoype home-based self screening & remote monitoring plan- using the Terason 3200T. For 7 days, a Terason technical representative partnered with our radiology team to conduct the daily monitoring in real-time both through video conferencing & scan/file sharing from various geographic locations. Complete tracking reports, imaging logs and video interviews with the patient during the self-screening process made for a successful example of remote patient diagnostic access & group collaboration using WIFI technology & advanced digital communication. (See complete review)
MedTech* News Reports
As a cancer imaging specialist, I have the highest regard for all my colleagues who offer some of the most remarkable advancements in medical care. Major installations like the CyberKnife System, Proton Therapy, Robotic surgical technologies and the latest in AI-Powered MRI systems are just some of the breakthroughs shaping the battle against cancer and other disorders. I report on their many life-saving advantages and support the great science that goes into their development.
Originally Published in: The Journal of Modern Healing
The concept of the pencil beam scanning or IMPT (intensity-modulated proton therapy) has grown widely accepted as the ‘new future’ in radiation therapy. This dose is deposited within a controlled range of depth, affecting specific coordinates in the body so most of the dose is delivered to the actual tumor and little or no radiation is delivered to tissues beyond the tumor. This system is globally recognized to treat brain tumors, prostate, breast, liver, lung, head and neck, and other cancers. (SEE ARTICLE LINK)

is an electronic device that clips onto a patient’s finger to measure heart rate and oxygen saturation in his or her red blood cells—the device is useful in assessing patients with lung disease. Almost a year into the pandemic, we have seen waves of empty shelves of specific items due to panic shopping or the recent burst of proactive health trends. This reflects a significant part of "the Covid Culture"- comprising the demand for personal safety measures (beyond the holy trinity of masking, distancing and hand hygiene). (SEE ARTICLE LINK)

Since the first recorded successful surgical procedure in 1985 launched the trend of robotic assisted surgeries have widely expanded in growth and demand - supporting the complexities of Heart, Thoracic, Gastrointestinal, Gynecological, Spine, This review explores the latest work of Dr. Stephen Chagares, the first American surgeon to conduct the robotic mastectomy and his innovation of choice. (SEE ARTICLE LINK)

Since the advent of radiation therapy (and the invention of the x-ray) over a century ago, the noninvasive treatment approach of radiotherapy continues to be recognized as one of the most forward-thinking technologies in the pursuit of targeting cancer tumors. The CyberKnife® Robotic RadioSurgery System represents the latest performance innovation in this modality for treating benign and malignant tumors as well as other chronic disorders. (SEE ARTICLE LINK)

From Modern Diagnostic Science (8/2019)- by Dr. Manu Jain / MSKCC
(RCM) gives dermatologists a major upgrade (over age-old microscopy) in their ability to assess pathologic and physiologic conditions of the skin with a higher level of clinical accuracy, greatly supporting the reduction of calls for biopsies of benign lesions. This system gathers epidermal and superficial dermal information through the use of LIGHT and laser. It penetrates the skin to reach an estimated 200 microns in depth –often useful in dermatology to diagnose skin cancers like melanoma, basal cell carcinoma and squamous cell carcinoma. (SEE ARTICLE LINK)

Today's engineering and medical technology (from the late 1980s) show significant evidence of ethical standards and major consideration for patient response. Ethics in treatment engineering covers all angles considered about the innovation including: the way it is built, the materials applied, the engagement of the operator and the aftermath of the patient.. “Historically, radiation CAUSED cancer, but that's because you didn't have precision then....So the more precise you can be, the better - and we (Accuray) pride ourselves on exquisite and unparalleled precision,” says Ms. Fleurent. (SEE ARTICLE LINK)

Disclaimer: All content in the MedTech Reviews* and MedTech News* section are assembled excerpts of actual articles written, co-written or produced by Dr. Robert Bard and are published in the various media publications as stated. Each article in the form of medical technology feature reviews or educational reports are samples of Dr. Bard's body of work. The manufacturers / developers, medical centers, corporate entities or practitioners mentioned in these reviews are NOT presented on this page or the MedTech program for any commercial purposes nor have any direct business ties to the Angiofoundation or the producers/publishers in any way.

Dr. Bard is highly involved with public education both in the private and public circuits. These are just a few recent samples of his "social media shorts". For all his other media coverage including news features, please visit his media section by clicking THIS LINK.
The Fire Still Burns (Pilot 1) (Pilot 2) 12/2019 Article 1 | Article: CyberKnife
Curriculum Vitae (Updated 10/21/2018)
Contact Bard Cancer Diagnostics | 121 E 60th St. #6A New York, NY | (212) 355-7017